{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:34:01Z","timestamp":1770510841394,"version":"3.49.0"},"reference-count":46,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T00:00:00Z","timestamp":1309132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>1.\u2002Gallium arsenide (GaAs), a semiconductor, exerts toxicity as a result of its constitutive moieties; that is, gallium and arsenic that becomes dissociated after exposure. The present study focuses on reducing arsenic concentration from the target organs using monoesters of meso 2,3\u2010dimercaptosuccinic acid (DMSA) either individually or in combination.<\/jats:p><jats:p>2.\u2002Animals were exposed to GaAs (0.0014\u2003mol\/kg, orally for 8\u2003weeks) and then treated with monoisoamyl DMSA (MiADMSA), monocyclohexyl DMSA (MchDMSA) or monomethyl DMSA (MmDMSA) either individually (0.3\u2003mmol\/kg, orally) or in combination (0.15\u2003mmol\/kg each, orally) for five consecutive days.<\/jats:p><jats:p>3.\u2002GaAs exposure significantly inhibited blood \u03b4\u2010aminolevulinic acid dehydrogenase (ALAD), suggesting alterations in the heme synthesis pathway. Whereas a significant increase in blood, liver and kidney reactive oxygen species accompanied by an increase in lipid peroxidation points to the involvement of oxidative stress in GaAs toxicity.<\/jats:p><jats:p>4.\u2002GaAs also significantly disturbed glutathione metabolism. Hepatic and renal catalase activity decreased significantly, whereas hepatic and renal superoxide dismutase activity, as well as serum transaminases activity, showed marginal increase. Treatment with MiADMSA in combination with MchDMSA showed better therapeutic efficacy compared with other treatments in the aforementioned variables.<\/jats:p><jats:p>5.\u2002Co\u2010administration of MiADMSA with MchDMSA provided better therapeutic effects, including reduction of arsenic burden, compared with all other treatments.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2011.05529.x","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T12:02:19Z","timestamp":1303128139000},"page":"423-429","source":"Crossref","is-referenced-by-count":21,"title":["Co\u2010administration of meso 2,3\u2010dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats"],"prefix":"10.1111","volume":"38","author":[{"given":"Swaran JS","family":"Flora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhu","family":"Pachauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K","family":"Kushwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,27]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"27","volume-title":"Handbook on the Toxicology of Metals","author":"Fowler BA","year":"2007"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(86)90276-0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1539\/joh.42.105"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(88)90378-X"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx700315a"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2009.03.012"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2009.05.013"},{"key":"e_1_2_6_9_2","unstructured":"HauserW WegerN.Treatment of arsenic poisoning in mice with sodium dimercaptopropane 1\u2010sulfonate. In Proc. Inter. Cong. Pharmacol. Paris 1989; (Abstract)."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259591"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2003.09.010"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-002-0347-5"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph7072745"},{"key":"e_1_2_6_14_2","first-page":"8064","article-title":"Quercetin administration during chelation therapy protects arsenic\u2010induced oxidative stress in mice","volume":"7","author":"Mishra D","year":"2008","journal-title":"Biol. Trace Elem. Res."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1081\/ESE-120016892"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(02)00034-6"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00142009"},{"key":"e_1_2_6_18_2","first-page":"333","article-title":"Arsenic induced oxidative stress and role of antioxidant supplementation during chelation: A review","volume":"28","author":"Flora SJS","year":"2007","journal-title":"J. Environ. Biol."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1995.tb01015.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659209017938"},{"key":"e_1_2_6_21_2","first-page":"389","article-title":"European standardized method for the determination of delta aminolevulinic acid dehydratase activity in blood","volume":"12","author":"Berlin A","year":"1974","journal-title":"Z. Klin. Chem. Klin. Biochem."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(59)90090-6"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000136485"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6969"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90326-2"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(84)05015-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"e_1_2_6_28_2","first-page":"130","article-title":"A modified spectrophotometric assay of superoxide dismutase","volume":"21","author":"Kakkar P","year":"1984","journal-title":"Indian J. Biochem. Biophys."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(72)90132-7"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/28.1.56"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389557043487583"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.04.008"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1992.tb00483.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.04.007"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(94)03601-4"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.1999.03157.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.04.016"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/clinchem\/31.10.1673","article-title":"Oxygen toxicity related to exposure to lead","volume":"31","author":"Monteiro HR","year":"1985","journal-title":"Clin. Chem."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2001.9157"},{"key":"e_1_2_6_40_2","first-page":"706","article-title":"Inevitable glutathione, then and now","volume":"40","author":"Rana SVS","year":"2002","journal-title":"Indian J. Exp. Biol."},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.126342"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.07.004"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.057919"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(00)00048-5"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(98)00074-2"},{"key":"e_1_2_6_46_2","first-page":"228","article-title":"Beneficial role of zinc and iron co\u2010administration during gallium arsenide exposure in rats","volume":"2","author":"Bhatt K","year":"2008","journal-title":"Curr. Trend Biotechnol. Pharmacy"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-0134(99)00155-5"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2011.05529.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2011.05529.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:13:35Z","timestamp":1697382815000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2011.05529.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,27]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1440-1681.2011.05529.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2011.05529.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,27]]}}}